1. Home
  2. NEOG vs NVCR Comparison

NEOG vs NVCR Comparison

Compare NEOG & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neogen Corporation

NEOG

Neogen Corporation

N/A

Current Price

$10.80

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Logo NovoCure Limited

NVCR

NovoCure Limited

N/A

Current Price

$10.14

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NEOG
NVCR
Founded
1981
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
1989
2015

Fundamental Metrics

Financial Performance
Metric
NEOG
NVCR
Price
$10.80
$10.14
Analyst Decision
Buy
Buy
Analyst Count
4
6
Target Price
$10.67
$26.42
AVG Volume (30 Days)
4.6M
1.4M
Earning Date
01-08-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$880,319,000.00
$642,269,000.00
Revenue This Year
N/A
$10.64
Revenue Next Year
$2.00
$5.37
P/E Ratio
N/A
N/A
Revenue Growth
N/A
11.17
52 Week Low
$3.87
$9.82
52 Week High
$10.91
$24.73

Technical Indicators

Market Signals
Indicator
NEOG
NVCR
Relative Strength Index (RSI) 78.49 27.03
Support Level $9.94 $9.82
Resistance Level $10.90 $12.91
Average True Range (ATR) 0.45 0.63
MACD -0.02 -0.36
Stochastic Oscillator 89.85 10.51

Price Performance

Historical Comparison
NEOG
NVCR

About NEOG Neogen Corporation

Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

Share on Social Networks: